نتایج جستجو برای: central serous chorioretinopathy

تعداد نتایج: 477771  

Journal: :JPMA. The Journal of the Pakistan Medical Association 2013
Ahmad Zeeshan Jamil Khurram Azam Mirza Zaheer Uddin Aqil Qazi Wasim Iqbal Javed Khaliq Fawad-ur-Rahman Arslan Ahmed

OBJECTIVE To evaluate the clinical, angiographic and optical coherence tomographic features of central serous chorioretinopathy in patients presenting at a tertiary care centre in Lahore. METHODS The observational study was conducted at the Layton Rehmatulla Benevolent Trust Eye and Cancer Hospital Lahore from July 15, 2010 to December 15, 2011. Patients who had received prior treatment for t...

2017
Zafer Cebeci Merih Oray Şerife Bayraktar İlknur Tuğal-Tutkun Nur Kır

Bullous central serous chorioretinopathy (CSCR) is a rare variant of CSCR characterized by severe serous retinal detachment which especially involves the inferior quadrants. Corticosteroid therapy administered for systemic or ocular misdiagnoses may induce and exacerbate CSCR. The purpose of this study was to report diagnosis and treatment results of an unusual case of bullous CSCR induced by s...

Journal: :The British journal of ophthalmology 1995
J Kondrová

Journal: :Asian Journal of Ophthalmology 1970

Journal: :Indian Journal of Ophthalmology 2015

Journal: :The Eurasian journal of medicine 2009
İlknur Akyol-Salman Deniz Leçe-Sertöz Uğur Mumcu Orhan Ateş Orhan Baykal

Central serous chorioretinopathy (CSC) is an idiopathic disorder characterized by serous detachment of the neurosensory retina. This report describes a case of CSC associated with rowatinex usage.

2015
Elodie Bousquet Talal Beydoun Pierre-Raphaël Rothschild Ciara Bergin Min Zhao Rui Batista Marie-Laure Brandely Benedicte Couraud Nicolette Farman Alain Gaudric François Chast Francine Behar-Cohen

Purpose: To evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, for nonresolving central serous chorioretinopathy. Methods: This is a prospective, randomized, double-blinded, placebo-controlled crossover study. Sixteen eyes of 16 patients with central serous chorioretinopathy and persistent subretinal fluid (SRF) for at least 3 months were enrolled. Patients were ran...

2014
Julie M. Rosenthal Christina J. Flaxel

Background: Chronic central serous chorioretinopathy presents a treatment challenge. Photodynamic therapy has been used successfully but with side effects; thus, the authors explored half-dose and half-fluence photodynamic therapy as lower-risk alternatives. Methods: Retrospective medical record review of patients with chronic or recurrent central serous chorioretinopathy who received half-dose...

Journal: :Archivos de la Sociedad Espanola de Oftalmologia 2011
I Gregori-Gisbert F Aguirre-Balsalobre J García-Sánchez G León-Salvatierra E Mengual-Verdú J R Hueso-Abancéns

PURPOSE To evaluate the efficacy of intavitreal injection of bevacizumab in patients with chronic central serous chorioretinopathy. METHODS A study of 8 patients with central serous chorioretinopathy who were treated with intravitreal injection of bevacizumab. We studied the visual acuity with Snelleńs method and the foveal thickness, before and after the injection. RESULTS The mean age of ...

2012
Santiago Antonio B. Sibayan

von Humboldt Foundation, Bonn, Germany. ABSTRACT Objective The pathogenesis of central serous chorioretinopathy is poorly understood. It is believed to be due to dysfunction of the retinal pigment epithelium and/or choroid, and has been associated with elevated levels of epinephrine and administration of corticosteroids. Epinephrine and corticosteroids have previously been shown to induce apopt...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید